176 filings
Page 6 of 9
6-K
okfs5r
14 Aug 12
Report of Foreign Issuer for the Period Ended June 30, 2012
12:00am
6-K
xdjmi2
15 May 12
Report of Foreign Issuer for the Period Ended March 31, 2012
12:00am
6-K
2eigb96ev1n8a
20 Apr 12
Notice of the Annual General Meeting of the Shareholders
12:00am
6-K
fhmvwfibss9ial q6rj
15 Mar 12
Report of Foreign Issuer for the Period Ended December 31, 2011
12:00am
6-K
m0n1x y4l6q
1 Mar 12
Nymox Announces U.S. Phase 2 Clinical Trial of NX-1207 for New Indication - Prostate Cancer
12:00am
6-K
op7lm1ow9t1ggm
21 Feb 12
Recordati and Nymox Announce The Start of European Phase III Clinical Trial for NX-1207
12:00am
6-K
ecnk8fci52tzof
14 Nov 11
Report of Foreign Issuer for the Period Ended September 30, 2011
12:00am
6-K
55942xvm
12 Aug 11
Report of Foreign Issuer for the Period Ended June 30, 2011
12:00am
6-K
cv6ja1e iw0nmjtspgqf
13 May 11
Report of Foreign Issuer for the Period Ended March 31, 2011
12:00am
6-K
l1sagiu04d rwg69o
21 Apr 11
Notice of the Annual General Meeting of the Shareholders
12:00am
6-K
x33k17169ly
15 Mar 11
Report of Foreign Issuer for the Period Ended December 31, 2010
12:00am
6-K
nvlup 2qsqxzq
17 Dec 10
Recordati and Nymox Pharmaceutical Corporation Announce European Licensing Agreement for NX-1207
12:00am
6-K
tw6rjfjdxu75 aec
12 Nov 10
Report of Foreign Issuer for the Period Ended September 30, 2010
12:00am
6-K
wf0cea8w73un
13 Aug 10
Report of Foreign Issuer for the Period Ended June 30, 2010
12:00am
6-K
zdqr4y
14 May 10
Report of Foreign Issuer for the Period Ended March 31, 2010
12:00am
6-K
2nbtim
23 Apr 10
Notice of the Annual General Meeting of the Shareholders
12:00am
6-K
cxu7loo7
11 Mar 10
Report of Foreign Issuer for the Period Ended December 31, 2009
12:00am
6-K
zejw5u
13 Nov 09
Report of Foreign Issuer
12:00am
6-K
cj2x h66galg
14 Aug 09
Report of Foreign Issuer
12:00am
6-K
vw5cvkorh1 efw
3 Jun 09
Report of Foreign Issuer
12:00am